Article

Predicting malignancy in pre-neoplastic lesions detected during screening for pancreatic cancer

2017-01-01

Abstract excerpt

Background: Screening is offered to individuals who have an identified increased risk of pancreatic cancer. Such risks may be increased because of a family history or a known genetic mutation which has been shown to confer increased risk. Amongst those being screened intraductal papillary mucinous neoplasm (IPMN) of the pancreas are increasingly common entities being detected incidentally; their risk of malignancy...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ded26ec7-01bf-5fb6-8898-88842bcd3112
DOI: 10.17638/03008012

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Predicting malignancy in pre-neoplastic lesions detected during screening for pancreatic cancerDOI 10.17638/03008012Read

Pancreatic cancer screening in a prospective cohort of high-risk patients: a comprehensive strategy of imaging and genetics.Semantic proximity Read

International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer.Semantic proximity Read

Intraductal Papillary Mucinous Neoplasms in Hereditary Cancer SyndromesSemantic proximity Read

Enhancing Early Detection of Pancreatic Cancer in Genetically Predisposed Individuals: Integrating Advanced Imaging Modalities with Emerging Biomarkers and Liquid BiopsySemantic proximity Read

Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium.Semantic proximity Read

Patients with deleterious germline mutations: A heterogeneous population for pancreatic cancer screening?Semantic proximity Read

Individuals at high-risk for pancreatic cancer development: management options and the role of surgery.Semantic proximity Read

Pancreatic Cancer Detection in Intraductal Papillary Mucinous Neoplasm (IPMN) – New InsightsSemantic proximity Read

Pancreatic cancer screening is effective in individuals at risk with predisposing germline gene variants, but not in gene variant-negative familial pancreatic cancer families.Semantic proximity Read

Screening of Patients at Risk for Familial Pancreatic Cancer: What Is Beneﬁcial?Semantic proximity Read

Pancreatic cancer screening in high-risk individuals with germline genetic mutations.Semantic proximity Read

The Use of Integrated Molecular Testing in the Assessment and Management of Pancreatic Cysts.Semantic proximity Read